Skip to content

A Randomised controlled clinical study to evaluate the efficacy of Ayurvedic formulation in the management of primary hypertension

A Randomized controlled clinical study to evaluate the efficacy of Ayurvedic formulation formulation in the management of primary hypertension

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078845
Enrollment
62
Registered
2025-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: kwath (Decoction): Guduchi + Duralabha + Rakta chandan + Patol + Aragvadha + Shunthi + dhanyak Dose : 50ml BD Route of administration: Oral Duration: 14days Control Intervention1: Tabl

Sponsors

Dr Archi Saraf
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Systolic Blood pressure - less than 180 mm of Hg more than and equal to 140 mm of Hg Diastolic Blood pressure - less than 110 mm of Hg more than and equal to 90 mm of Hg newly diagnosed patients

Exclusion criteria

Exclusion criteria: Secondary hypertension Alcoholic and Drug abusers pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Reduction in Blood pressureTimepoint: 14 days with follow ups of 7th and 14th day

Secondary

MeasureTime frame
Reduction in symptoms of primary hypertension like headache, giddiness, fatigue, insomnia, perspiration, palpitationTimepoint: 14 days with follow ups of 7th and 14th day

Countries

India

Contacts

Public ContactDr Archi Saraf

Dr. D. Y. Patil College of Ayurveda and Research centre, Pimpri, PUNE

gunvantayurved@gmail.com9028321955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026